SCHEMBL12384824

SCHEMBL12384824

O=C(O)CSc1cnc(NC(=O)NC(=O)N(C2CCCCC2)C2CCCCC2)s1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 13/20 0.41
▸ CDK2 P24941 13/20 0.41
▸ CCNE2 O96020 11/20 0.41
▸ CCNB2 O95067 4/20 0.41
▸ CDK1 P06493 4/20 0.41
▸ CDK4 P11802 4/20 0.41
▸ CCNB1 P14635 4/20 0.41
▸ CCND1 P24385 4/20 0.41
▸ CCNB3 Q8WWL7 4/20 0.41
▸ CDK5 Q00535 2/20 0.38
▸ ATG4B Q9Y4P1 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GCK P35557 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ GRM4 Q14833 1/20 0.35
▸ CDK9 P50750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12384828 0.94 CDK2 (0.39) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL999233 0.91 CCNE1 (0.43) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL1000176 0.91 CCNE1 (0.43) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL998518 0.91 CCNE1 (0.43) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL999125 0.91 CCNE1 (0.43) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL999286 0.91 CCNE1 (0.43) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL12384835 0.89 CCNE1 (0.40) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL1000587 0.88 CCNE1 (0.40) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL1000238 0.88 CDK2 (0.40) CCNE1CDK2CCNE2CCNB2CDK1
SCHEMBL1000240 0.88 CDK2 (0.40) CCNE1CDK2CCNE2CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999114-B2 Dicycloalkylcarbamoyl ureas as glucokinase activators NOVO NORDISK A/S (DK) 2011-08-16 — — US disclosed
US-7999114-B2 Dicycloalkylcarbamoyl ureas as glucokinase activators NOVO NORDISK A/S (DK) 2011-08-16 — — US disclosed
US-20080319028-A1 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators NOVO NORDISK A/S (DK) 2008-12-25 — — US disclosed
US-20080319028-A1 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators NOVO NORDISK A/S (DK) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319028-A1 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators GCK, HK1, GCKR CCNE1 2708/4885CDK2 547/4885CCNE2 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback